Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
or

Cara Therapeutics (CARA)

Cara Therapeutics (CARA)
N/A x N/A N/A x N/A
Pre-market by (Cboe BZX)
5.32 -0.23 (-4.14%) 04/15/25 [NASDAQ]
N/A x N/A N/A x N/A
Pre-market 5.32 unch (unch) 16:00 ET
Quote Overview for Tue, Apr 15th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
5.28
Day High
5.52
Open 5.39
Previous Close 5.55 5.55
Volume 237,100 237,100
Avg Vol 30,465 30,465
Stochastic %K 61.54% 61.54%
Weighted Alpha -27.45 -27.45
5-Day Change +0.47 (+9.69%) +0.47 (+9.69%)
52-Week Range 2.71 - 10.44 2.71 - 10.44
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 24,332
  • Shares Outstanding, K 4,574
  • Annual Sales, $ 7,140 K
  • Annual Income, $ -70,870 K
  • EBIT $ -58 M
  • EBITDA $ -58 M
  • 60-Month Beta 0.41
  • Price/Sales 3.56
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -12.96
  • Most Recent Earnings $-1.80 on 11/14/24
  • Next Earnings Date 05/12/25 [--]
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Biomedical

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -6.72
  • Growth Rate Est. (year over year) +14,966.07%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.52 +17.70%
on 04/07/25
Period Open: 5.13
5.75 -7.48%
on 04/14/25
+0.19 (+3.70%)
since 03/14/25
3-Month
4.30 +23.72%
on 03/05/25
Period Open: 4.46
6.00 -11.33%
on 01/27/25
+0.86 (+19.28%)
since 01/15/25
52-Week
2.71 +96.43%
on 12/18/24
Period Open: 8.52
10.44 -49.04%
on 05/16/24
-3.20 (-37.56%)
since 04/15/24

Most Recent Stories

More News
Cara Therapeutics Stock Jumps 10% After Announcing 1-for-3 Reverse Stock Split: Retail Sentiment Soars

On Tuesday evening, every three issued and outstanding shares of CARA’s common stock will automatically be combined into one, effectively reducing the number of issued and outstanding shares of the company's...

CARA : 5.32 (-4.14%)
VXF : 170.00 (+0.27%)
VTI : 270.64 (+0.61%)
Cara Therapeutics Announces 1-for-3 Reverse Stock Split in Connection with the Proposed Merger with Tvardi Therapeutics

CARA : 5.32 (-4.14%)
Cara Therapeutics Announces Effective Date of 1-for-12 Reverse Stock Split

CARA : 5.32 (-4.14%)
Cara: Q3 Earnings Snapshot

Cara: Q3 Earnings Snapshot

CARA : 5.32 (-4.14%)
Cara: Q2 Earnings Snapshot

Cara: Q2 Earnings Snapshot

CARA : 5.32 (-4.14%)
Cara: Q1 Earnings Snapshot

Cara: Q1 Earnings Snapshot

CARA : 5.32 (-4.14%)
Cara: Q4 Earnings Snapshot

Cara: Q4 Earnings Snapshot

CARA : 5.32 (-4.14%)
Mira Pharmaceuticals Stock Is Soaring In November... Here's Why

Leveraging a favorable DEA classification for its synthetic analog of THC, Mira Pharmaceuticals could be on an expedited pathway toward commercialization to treat several unmet neurological m

CARA : 5.32 (-4.14%)
CRBP : 8.08 (-3.23%)
JAZZ : 110.80 (+1.67%)
HRMY : 29.61 (+0.61%)
MIRA : 1.0400 (+4.61%)
Cara: Q3 Earnings Snapshot

Cara: Q3 Earnings Snapshot

CARA : 5.32 (-4.14%)
Cara: Q2 Earnings Snapshot

Cara: Q2 Earnings Snapshot

CARA : 5.32 (-4.14%)

Business Summary

Cara Therapeutics, Inc. is a biopharmaceutical company. The company is focused on developing and commercializing new chemical entities designed to alleviate pain. Cara Therapeutics, Inc. is based in Shelton, United States.

See More

Key Turning Points

3rd Resistance Point 5.71
2nd Resistance Point 5.61
1st Resistance Point 5.47
Last Price 5.32
1st Support Level 5.23
2nd Support Level 5.13
3rd Support Level 4.99

See More

52-Week High 10.44
Fibonacci 61.8% 7.49
Fibonacci 50% 6.57
Fibonacci 38.2% 5.66
Last Price 5.32
52-Week Low 2.71

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective